Overview

Rucaparib in Nonmetastatic prOstAte With BRCAness

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This is a single arm, open label, phase II trial to assess efficacy of rucaparib.
Phase:
Phase 2
Details
Lead Sponsor:
University of Utah
Collaborator:
Clovis Oncology, Inc.
Treatments:
Rucaparib